Premium
Suppression of human melanoma cell growth and metastasis by the melanoma‐associated antigen CD63 (ME491)
Author(s) -
Radford Kristen J.,
Mallesch Julia,
Mersey Peter
Publication year - 1995
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.2910620523
Subject(s) - melanoma , transfection , monoclonal antibody , cancer research , metastasis , cell culture , antigen , biology , antibody , in vitro , medicine , immunology , cancer , biochemistry , genetics
CD63 has been identified in human melanoma cells by a number of different monoclonal antibodies (MAbs). Studies with MAbs have shown that expression is most marked in naevi and early forms of cutaneous melanoma and reduced in vertical growth phase and metastatic lesions. To investigate further the role of CD63 in progression of melanoma, genomic CD63 was transfected into a CD63‐negative human melanoma cell line using an episomal vector. The stable transfected melanoma cells had similar growth rates to control transfected melanoma cells in vitro but much lower growth rates when injected intradermally into athymic nude mice. The CD63‐transfected cells also had a reduced number of metastases in the peritoneal cavity and subcutaneous sites when injected intravenously. MAb against CD63 did not influence the growth of CO63‐transfected melanoma cells in vitro. Our results confirm previous studies using H‐ros‐transformed NIH3T3 fibroblasts and suggest that CD63 may have a role as a tumor suppressor gene in human melanoma that acts to limit invasion and progression of melanoma. © 1995 Wiley‐Liss, Inc.